Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Regeneron Pharmaceutical (REGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Regeneron Announces ANGPTL3/Evinacumab Publication in New England Journal of Medicine and Positive Phase 2 Data in People with HoFH

ANGPTL3 genetics publication and evinacumab data presentation highlight Regeneron's integrated drug development process

REGN : 458.24 (-0.68%)
Theravance/Mylan Presents Phase III Data on COPD Candidate

Theravance Biopharma, Inc. (TBPH) and partner Mylan recently announced the presentation of additional efficacy and safety data from two pivotal phase III studies evaluating its key pipeline candidate,...

TBPH : 36.89 (+0.99%)
MYL : 39.18 (-1.04%)
VVUS : 1.10 (-1.79%)
REGN : 458.24 (-0.68%)
Blog Coverage: Celgene Reported Positive Late Stage Results from Trial of Ozanimod in Patients with Relapsing Multiple Sclerosis

Upcoming AWS Coverage on Regeneron Pharmaceuticals Post-Earnings Results

CELG : 117.75 (+0.38%)
REGN : 458.24 (-0.68%)
CELGZ : 1.17 (-0.85%)
Charter's Rutledge, CBS's Moonves among highest-paid CEOs

Here are the 10 highest-paid CEOs for 2016, as calculated by The Associated Press and Equilar, an executive data firm.

ATVI : 58.51 (+1.23%)
WYNN : 124.00 (-0.12%)
CHTR : 329.04 (+3.22%)
REGN : 458.24 (-0.68%)
DISCA : 25.46 (-0.66%)
SmarTrend Watching for Potential Pullback in Shares of Regeneron Pharmaceuticals After 3.18% Gain

Regeneron Pharmaceuticals (NASDAQ:REGN) traded in a range yesterday that spanned from a low of $448.39 to a high of $464.39. Yesterday, the shares gained 3.2%, which took the trading range above the...

REGN : 458.24 (-0.68%)
Merck's HIV Drug Gets Positive CHMP Opinion for Higher Dose

Merck & Co., Inc. (MRK) recently announced that the 600 mg film-coated formulation of its marketed drug, Isentress (raltegravir) in combination with other anti-retroviral therapies, has received positive...

VVUS : 1.10 (-1.79%)
MRK : 64.93 (+0.59%)
GILD : 64.31 (-0.59%)
REGN : 458.24 (-0.68%)
Compugen (CGEN) Worth a Look: Stock Adds 10.4% in Session

Compugen Ltd. (CGEN) shares rose over 10% in the last trading session.

CGEN : 5.35 (+0.94%)
REGN : 458.24 (-0.68%)
Regeneron, Nuance Communications, Waste Management, Waste Connections and Republic Services highlighted as Zacks Bull and Bear of the Day

Regeneron, Nuance Communications, Waste Management, Waste Connections and Republic Services highlighted as Zacks Bull and Bear of the Day

NUAN : 18.79 (-0.16%)
WCN : 93.13 (+0.78%)
WM : 71.38 (+0.51%)
RSG : 62.41 (+0.08%)
REGN : 458.24 (-0.68%)
Biotech Stock Roundup: Biogen Inks Deal to Boost Pipeline, Sangamo Soars on Pfizer Deal

Quite a few deals were announced this week including by companies like Biogen (BIIB).

SGMO : 8.15 (-0.61%)
AKBA : 14.24 (+2.08%)
VRTX : 117.80 (+1.04%)
IONS : 46.55 (+3.12%)
REGN : 458.24 (-0.68%)
ALXN : 101.08 (-3.40%)
BIIB : 253.33 (+2.11%)
Bull of the Day: Regeneron (REGN)

Bull of the Day: Regeneron (REGN)

REGN : 458.24 (-0.68%)
SNY : 49.15 (+0.16%)
Bull of the Day: Regeneron (REGN)

Bull of the Day: Regeneron (REGN)

REGN : 458.24 (-0.68%)
SNY : 49.15 (+0.16%)
TransEnterix (TRXC) Reports Wider-than-Expected Loss in Q1

TransEnterix, Inc. (TRXC) reported a loss of 13 cents per share in the first quarter of 2017, wider than the Zacks Consensus Estimate of a loss of 12 cents.

BAX : 58.34 (+0.73%)
BIO : 218.95 (-0.19%)
REGN : 458.24 (-0.68%)
TRXC : 0.51 (-3.77%)
Bear of the Day: AMAG Pharmaceuticals (AMAG)

Bear of the Day: AMAG Pharmaceuticals (AMAG)

AKTX : 6.51 (-9.21%)
CBIO : 4.06 (+1.50%)
REGN : 458.24 (-0.68%)
AMAG : 19.25 (+6.35%)
Bear of the Day: AMAG Pharmaceuticals (AMAG)

Bear of the Day: AMAG Pharmaceuticals (AMAG)

AKTX : 6.51 (-9.21%)
CBIO : 4.06 (+1.50%)
REGN : 458.24 (-0.68%)
AMAG : 19.25 (+6.35%)
Look for Shares of Regeneron Pharmaceuticals to Potentially Pullback after Yesterday's 1.96% Rise

Regeneron Pharmaceuticals (NASDAQ:REGN) traded in a range yesterday that spanned from a low of $438.59 to a high of $452.88. Yesterday, the shares gained 2.0%, which took the trading range above the...

REGN : 458.24 (-0.68%)
Masimo (MASI) Beats on Q1 Earnings and Revenues, Guides Up

Masimo Corp. (MASI) reported earnings of 57 cents per share in the first quarter of 2017, outperforming the Zacks Consensus Estimate of 54 cents and improving from the year-ago quarterly earnings of 53...

MASI : 85.84 (+0.01%)
BAX : 58.34 (+0.73%)
BIO : 218.95 (-0.19%)
REGN : 458.24 (-0.68%)
Medtronic (MDT) Wins FDA Approval for CRT-P SureScan Suite

Medtronic plc (MDT) recently won FDA approval for a portfolio of quadripolar cardiac resynchronization therapy-pacemakers that improve therapy delivery for patients with heart failure.

BAX : 58.34 (+0.73%)
BIO : 218.95 (-0.19%)
MDT : 84.70 (+0.11%)
REGN : 458.24 (-0.68%)
STERIS (STE) Grapples with Headwinds: Should You Dump?

On May 10, we issued an updated research report on STERIS Plc (STE) which manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support...

STE : 76.67 (+0.51%)
BAX : 58.34 (+0.73%)
BIO : 218.95 (-0.19%)
REGN : 458.24 (-0.68%)
Hologic (HOLX) Tops Q2 Earnings & Sales, Raises 2017 View

Hologic Inc. (HOLX) reported second-quarter fiscal 2017 adjusted earnings per share (EPS) of 50 cents, up 6.4% year over year.

HOLX : 43.00 (+0.26%)
BAX : 58.34 (+0.73%)
BIO : 218.95 (-0.19%)
REGN : 458.24 (-0.68%)
Genomic Health (GHDX) Misses Q1 Earnings & Sales Estimates

Genomic Health, Inc. (GHDX) reported first-quarter 2017 loss per share of 7 cents, reflecting an improvement from the year-ago quarter's loss figure of 19 cents.

GHDX : 29.00 (-1.26%)
BAX : 58.34 (+0.73%)
BIO : 218.95 (-0.19%)
REGN : 458.24 (-0.68%)

Van Meerten Stock Picks

5 All Time High Large Caps for Momentum Investors
This morning I wanted to find 5 Large Caps that hit All Time Highs that might be of interest to Momentum Investors.
AON +0.63 , BAP -1.16 , BF.B +0.96 , VEEV +0.58 , ROL +0.32
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Jun E-mini S&Ps ( ESM17 -0.02% ) this morning are down -0.03% and European stocks are down -0.26% after the ECB warned in its Financial Stability Review that "risks to financial stability stemming from... Read More

Chart of the Day

Equinix (EQIX) is the Barchart Chart of the Day.  The computer building REIT has  Trend Spotter buy signal, a Weighted Alpha of 26.71 and gained 24.09% in the last year.
Read More

Brugler Ag Report

Today's Commentary

Corn futures closed 1 3/4 to 2 cents higher. The weekly EIA report this morning had daily ethanol production at 1.01 million barrels per day last week. It showed ethanol production dropping 17,000 bpd over the week of May 19. Ethanol stocks dropped b...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.